Patents by Inventor Stanford Salvatore Pelosi, Jr.

Stanford Salvatore Pelosi, Jr. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclic ureas useful as antiarrhythmic and antifibrillatory agents
    Patent number: 6083945
    Abstract: Disclosed are cyclic urea-containing compounds that are useful as antiarrhythmic and/or antifibrillatory agents. These compounds have the following structure: ##STR1## where X and Y are each independently selected from various cyclic moieties; R.sub.5 is a substituted or unsubstituted C.sub.2 alkyl (thus providing a 6-membered cyclic urea); and R.sub.1, R.sub.2, R.sub.3, R.sub.4, L, and A are as defined in the specification. Also disclosed are compositions containing the compounds and methods of treating humans or other mammals afflicted with cardiac arrhythmias and/or cardiac fibrillation by administration of the compounds/compositions.
    Type: Grant
    Filed: September 10, 1997
    Date of Patent: July 4, 2000
    Assignee: The Procter & Gamble Company
    Inventors: Stanford Salvatore Pelosi, Jr., Chia-Nien Yu
  • Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents
    Patent number: 5994354
    Abstract: The novel cyclic urethanes, and their pharmaceutically-acceptable salts and esters, described herein which are useful as antiarrhythmic and antifibrillatory agents and have the following general structure: ##STR1## wherein (a) X is a saturated or unsaturated, 5-, 6-, or 7-membered heterocycle or carbocycle;(b) Y is a substituted or unsubstituted, saturated or unsaturated, 5-, 6-, or 7-membered heterocyclic ring or carbocyclic ring, or is nil;(c) L is selected from the group consisting of alkylamino, alkenylamino, alkylimino, alkenylimino and acylamino; wherein the nitrogen atom thereof is bound to the nitrogen atom at the 3-position of the cyclic urethane ring moiety;(d) A is a substituted or unsubstituted, saturated or unsaturated, straight-chain or branched, C.sub.1 -C.sub.8 heteroalkyl; or a substituted or unsubstituted, saturated or unsaturated heterocycle having 6- or 7-members which may not have an oxygen atom; and A has one nitrogen atom which is adjacent to R.sub.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 30, 1999
    Assignee: The Procter & Gamble Company
    Inventors: Stanford Salvatore Pelosi, Jr., Chia-Nien Yu
  • Cyclic ureas useful as antiarrhythmic and antifibrillatory agents
    Patent number: 5691369
    Abstract: The cyclic ureas, and the pharmaceutically-acceptable salts and esters thereof, of the present invention are useful as antiarrhythmic and antifibrillatory agents and have the following general structure: ##STR1## wherein X, Y, A, L, R, R.sub.1, R.sub.2, R.sub.3, R.sub.4, and R.sub.5 are defined as in the Specification.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: November 25, 1997
    Assignee: The Proctor & Gamble Company
    Inventors: Stanford Salvatore Pelosi, Jr., Chia-Nien Yu
  • Antibacterial thiocyanatobenzothiazoles
    Patent number: 4028374
    Abstract: Certain thiocyanatobenzothiazoles of the formula: ##STR1## wherein R is hydrogen, 4-bromo, 4-chloro, 4-fluoro, 3,4-dichloro or 4-nitro; R.sub.1 is methoxy or thiocyanato; R.sub.2 is n-butyl, chloro, methyl, or thiocyanato; and R.sub.3 is hydrogen or chloro are effective antibacterial agents.
    Type: Grant
    Filed: November 3, 1975
    Date of Patent: June 7, 1977
    Assignee: Morton-Norwich Products, Inc.
    Inventors: Stanford Salvatore Pelosi, Jr., Robert James Alaimo
  • 6-Chloro-2-(3,4-dichloroanilino)-4H-3,1-benzothiazine
    Patent number: 4002621
    Abstract: 6-Chloro-2-(3,4-dichloroanilino)-4H-3,1-benzothiazine is an effective antibacterial agent.
    Type: Grant
    Filed: October 30, 1975
    Date of Patent: January 11, 1977
    Assignee: Morton-Norwich Products, Inc.
    Inventor: Stanford Salvatore Pelosi, Jr.
  • 2-(3-Chloroanilino)-4H-3,1-benzothiazine
    Patent number: 4002622
    Abstract: 2(3-Chloroanilino)-4H-3,1-benzothiazine is an effective anthelmintic agent.
    Type: Grant
    Filed: October 30, 1975
    Date of Patent: January 11, 1977
    Assignee: Morton-Norwich Products, Inc.
    Inventor: Stanford Salvatore Pelosi, Jr.